Flortaucipir f 18
Tauvid (flortaucipir f 18) is a small molecule pharmaceutical. Flortaucipir f 18 was first approved as Tauvid on 2020-05-28.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
Tauvid
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Flortaucipir f-18
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| TAUVID | Avid Radiopharmaceuticals | N-212123 RX | 2020-05-28 | 4 products, RLD, RS |
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| tauvid | New Drug Application | 2020-07-22 |
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
Expiration | Code | ||
|---|---|---|---|
FLORTAUCIPIR F-18, TAUVID, AVID RADIOPHARMS INC | |||
| 2025-05-28 | NCE | ||
Patent Expiration
Patent | Expires | Flag | FDA Information |
|---|---|---|---|
| Flortaucipir F-18, Tauvid, Avid Radiopharms Inc | |||
| 8932557 | 2029-05-19 | DP | |
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
56 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Alzheimer disease | D000544 | EFO_0000249 | F03 | 11 | 7 | 4 | 3 | 14 | 38 |
| Frontotemporal dementia | D057180 | G31.0 | 1 | 1 | — | 1 | 1 | 4 | |
| Dementia | D003704 | F03 | — | — | — | 1 | 2 | 3 | |
| Neuroimaging | D059906 | — | — | — | 1 | — | 1 | ||
| Whole body imaging | D051598 | — | — | — | 1 | — | 1 | ||
| Lewy body disease | D020961 | EFO_0006792 | G31.83 | — | — | — | 1 | — | 1 |
| Vascular dementia | D015140 | F01 | — | — | — | 1 | — | 1 |
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Neurodegenerative diseases | D019636 | EFO_0005772 | G31.9 | — | 1 | 1 | — | — | 1 |
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Traumatic brain injuries | D000070642 | S06 | 1 | 1 | — | — | 2 | 4 | |
| Chronic traumatic encephalopathy | D000070627 | — | 2 | — | — | — | 2 | ||
| Depression | D003863 | F33.9 | — | 1 | — | — | 1 | 2 | |
| Tauopathies | D024801 | — | 1 | — | — | — | 1 | ||
| Frontotemporal lobar degeneration | D057174 | — | 1 | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | — | — | 2 | 2 | ||
| Post-traumatic stress disorders | D013313 | EFO_0001358 | F43.1 | — | — | — | — | 1 | 1 |
| Brain concussion | D001924 | S06.0 | — | — | — | — | 1 | 1 | |
| Hiv | D006678 | O98.7 | — | — | — | — | 1 | 1 | |
| Neurocognitive disorders | D019965 | F09 | — | — | — | — | 1 | 1 | |
| Amyotrophic lateral sclerosis | D000690 | EFO_0000253 | G12.21 | — | — | — | — | 1 | 1 |
| Primary progressive aphasia | D018888 | EFO_0009053 | G31.01 | — | — | — | — | 1 | 1 |
| Drive | D004328 | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | FLORTAUCIPIR F 18 |
| INN | flortaucipir (18f) |
| Description | Flortaucipir (18F), sold under the brand name Tauvid, is a radioactive diagnostic agent indicated for use with positron emission tomography (PET) imaging to image the brain.
|
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) | |
| Structure (InChI/SMILES or Protein Sequence) | [18F]c1ccc(-c2ccc3c(c2)[nH]c2ccncc23)cn1 |
Identifiers
| PDB | — |
| CAS-ID | 1522051-90-6 |
| RxCUI | — |
| ChEMBL ID | CHEMBL3545253 |
| ChEBI ID | — |
| PubChem CID | 70957463 |
| DrugBank | DB14914 |
| UNII ID | T1JP1KYU9O (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 188 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
0 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more